Mesenchymal stem cells: paradoxes of passaging
Related Experiment Video
Updated: Aug 24, 2026

Assessment of the Immunomodulatory Properties of Human Mesenchymal Stem Cells (MSCs)
Published on: December 24, 2015
Elisabeth H Javazon1, Kirstin J Beggs, Alan W Flake
1Children's Institute for Surgical Science, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Abstract:
The field of stem cell biology continues to evolve with the ongoing characterization of multiple types of stem cells with their inherent potential for experimental and clinical application. Mesenchymal stem cells (MSC) are one of the most promising stem cell types due to their availability and the relatively simple requirements for in vitro expansion and genetic manipulation. Multiple populations described as "MSCs" have now been isolated from various tissues in humans and other species using a variety of culture techniques. Despite extensive in vitro characterization, relatively little has been demonstrated regarding their in vivo biology and therapeutic potential. Nevertheless, clinical trials utilizing MSCs are currently underway. The aim of this review is to critically analyze the field of MSC biology, particularly with respect to the current paradox between in vitro promise and in vivo efficacy. It is the authors' opinion that until this paradox is better understood, therapeutic applications will remain limited.
Insights
Mesenchymal stem cells (MSCs) show great promise in labs, but their effectiveness in the body is not well understood. Further research is needed to bridge this gap for wider therapeutic use.
Area of Science:
- Stem cell biology
- Regenerative medicine
- Cellular therapeutics
Background:
- Mesenchymal stem cells (MSCs) are widely studied for their potential in experimental and clinical applications.
- MSCs are attractive due to accessibility and ease of in vitro manipulation.
- Numerous MSC populations exist across species and tissues, complicating standardization.
Purpose of the Study:
- To critically analyze the current state of Mesenchymal stem cell (MSC) biology.
- To address the discrepancy between in vitro potential and in vivo efficacy of MSCs.
- To evaluate the limitations for therapeutic applications.
Main Methods:
- Review of existing literature on Mesenchymal stem cell (MSC) biology.
- Critical analysis of in vitro and in vivo data.
- Assessment of current clinical trial status.
Main Results:
- Extensive in vitro characterization of MSCs is available.
- Limited data exists on the in vivo behavior and therapeutic outcomes of MSCs.
- Clinical trials are ongoing despite knowledge gaps.
Conclusions:
- A significant paradox exists between the in vitro promise and in vivo efficacy of Mesenchymal stem cells (MSCs).
- Understanding this paradox is crucial for advancing MSC-based therapies.
- Current therapeutic applications of MSCs may remain limited until this gap is resolved.
Related Concept Videos
Mesenchymal Stem Cells
Multipotency of Hematopoietic Stem Cells
Stem Cell Culture
Stem Cell Niche
Induced Pluripotent Stem Cells
Somatic cells are...
Tissue Renewal without Stem Cells
However, failure of such a system...

